AARP Research on menopause highlights the impact of this transition and its symptoms on women’s work life and personal life as well as their need for information and resources, and

affordable treatments.  This is an opportunity for employers, health care providers, the marketplace, and policy makers to improve the health and well-being of women in midlife and eliminate

the damaging stigma that is often attached to this natural life transition.  IMPACT ON WORK AND LIFE MENOPAUSE SYMPTOMS HAVE A NEGATIVE IMPACT ON LIFE AND WORK FOR MANY WOMEN. * Over half

(53%) of U.S. women in some phase of menopause say this transition has a negative (16%) or mixed (37%) impact on their sense of self, with women in perimenopause more likely than those

Representation, fielded July 31–August 21, 2024.] * Half (49%) of all female workers 35 and older say menopause has a negative impact on their day-to-day life and 4 in 10 (39%) say it has a

negative impact on their work life, with mood symptoms (24%) and hot flashes or sweating (22%) topping the list, followed by headaches and joint/muscle pain, urinary and vaginal problems,

and cognitive and concentration issues. Still, some female workers report that menopause has no impact on their work life (49%) or their day-to-day life (31%). [Source: Economic Impact of

Menopause: Individual and Collective Costs, fielded September 2023.] * Many U.S. employers report that they would characterize the impact of menopause on their female workers as negative

(37%), while 40% say this transition has had no impact or they just aren’t sure.  Only 23% say menopause has had a positive impact on their female workers.  [Source: Economic Impact of

Menopause: Individual and Collective Costs, fielded September 2023.] * Most women (75%) ages 40 to 89 say their menopause symptoms interfere with their lives, with 1 in 10 (9%) saying they

interfere a great deal or are debilitating. [Source: Menopause Experiences: Providers Can Do Better in Educating, Starting the Conversation, fielded April 2018.]   FEMALE WORKERS POWER

THROUGH THE WORKDAY DESPITE THE DISCOMFORT OF MENOPAUSE SYMPTOMS. * Over half (55%) of female workers 35 and older report taking no days off work over a year to manage their menopause

symptoms, and just 22% say they’ve taken between one and five days off work.  Not surprisingly, as the number of reported symptoms increases, the likelihood of missed days of work also

increases. [Source: Economic Impact of Menopause: Individual and Collective Costs, fielded September 2023.] * Conversely, only 16% of employers report that female workers have taken zero

days off over a year due to menopause and 17% say female workers have taken one to five days off.  But many (39%) employers admit it’s hard for them to say or they aren’t sure how many days

their female workers have taken off over a year due to menopause symptoms.  [Source: Economic Impact of Menopause: Individual and Collective Costs, fielded September 2023.]   THERE IS

CLEARLY A NEED FOR INFORMATION AND RESOURCES ON MENOPAUSE AMONG WOMEN AND_ _EMPLOYERS. * Among all women in any phase of menopause, most (80%) have looked for information related to

menopause in a variety of places with health professionals, friends and the internet being the top mentions. [Source:  Women's Aging Journey, Menopause and Media Representation, fielded

July 31–August 21, 2024] * Only 4% of female workers 35 and older report that information and guides for workers and managers about menopause are offered by their employer and nearly

two-thirds (63%) want them to be offered.  [Source: Economic Impact of Menopause: Individual and Collective Costs, fielded September 2023.] * Moreover, employers acknowledge a need for

information on menopause: Over a quarter (28%) say they do not offer menopause information or guides to workers or managers but over 2 in 3 (68%) would find this type of information useful.

[Source: Economic Impact of Menopause: Individual and Collective Costs, fielded September 2023.] * Even though nearly a third (31%) of women 35 and older say they have searched online for

information about declining hormone levels and 37% have searched for information on how menopause impacts a woman’s body, close to 1 in 3 (31%) feel “not informed” about changes in their

body resulting from a decline in hormone levels as they age.  [Source:  Perimenopause Is More Than Hot Flashes: What Women Need to Know, fielded September 24–October 4, 2020.] * One in 5

(19%) women 35 and older acknowledge they are not knowledgeable about the menopausal process and over a third (36%) report they were not prepared for the menopausal process. [Source: 

Perimenopause Is More Than Hot Flashes: What Women Need to Know, fielded September 24–October 4, 2020.] * Similarly, almost 1 in 3 (31%) women ages 40 to 89 said they don’t receive

information from any source about menopause, and over a third (36%) said they didn’t know enough about hormone replacement therapy to have an opinion about it.  [Source: Menopause

Experiences: Providers Can Do Better in Educating, Starting the Conversation, fielded April 2018.] TREATMENTS WOMEN NEED EFFECTIVE AND LOW-COST TREATMENTS FOR MENOPAUSE SYMPTOMS. *

Nonmedical approaches to treating menopause symptoms, such as vitamins and supplements, diet changes and cannabis, are more common than medical treatments like hormone replacement therapy.

For example, nearly half (45%) of female workers 35 and older have used supplements, while just 15% have tried hormone replacement therapy.  [Source: Economic Impact of Menopause: Individual

and Collective Costs, fielded September 2023.] * Yet almost three-quarters (72%) say they want their employer to provide access to hormone replacement therapy. Another two-thirds (68%)

would like to see their employer cover alternative treatments for menopause symptoms. Additionally, most (70%) would like access to menopause health professionals.  [Source: Economic Impact

of Menopause: Individual and Collective Costs, fielded September 2023.] * Combined co-pays and out-of-pocket spending on medical and nonmedical treatments together is costing U.S. women in

menopause about $13 billion a year.  [Source: Economic Impact of Menopause: Individual and Collective Costs, fielded September 2023.] * Four in 5 (80%) women overall cite interest in

noninvasive, tech-related solutions (e.g., a device that you wear, clothing, apps) to relieve or minimize menopausal symptoms. Among menopausal women, that proportion climbs even further

(93%). [Source: Menopausal Symptoms: There’s a Place for Tech-Related Solutions,  fielded December 6–12, 2019.] * Before treatment can be offered, some education may be needed. Most women 35

and older might not even know the range of conditions associated with perimenopause and menopause. When presented with a list of 28 conditions that can result in a decline in hormones due

to aging, only 7% knew all the conditions that could be associated with perimenopause or menopause. [Source:  Perimenopause Is More Than Hot Flashes: What Women Need to Know, fielded

September 24–October 4, 2020.] STIGMA THERE IS A STIGMA ATTACHED TO MENOPAUSE IN SOCIETY, THE MEDIA AND THE WORKPLACE.  * At least 1 in 7 women in any phase of menopause are concerned about

being stereotyped, treated differently or discriminated against based on menopause in media and advertisements (21% concerned), in personal interactions (18% concerned), when getting service

from a business they are a customer or client of (17% concerned) or at work (14% concerned).  [Source: Women's Aging Journey, Menopause and Media Representation, fielded July 31–August

21, 2024.] * Nearly 4 in 10 female workers 35-plus and employers think society at large has a negative view of menopause (workers, 38%; employers, 39%). [Source: Economic Impact of

Menopause: Individual and Collective Costs, fielded September 2023.] * Similarly, few women along the menopause continuum say that being in this transition has a positive impact on how

society values them (POSITIVE IMPACT: total, 7%; perimenopause, 5%; menopause, 12%; postmenopause, 7%). [Source: Economic Impact of Menopause: Individual and Collective Costs, fielded

September 2023.] * When it comes to the corporate culture toward menopause at their organizations, sizeable proportions of female workers 35-plus and employers describe it as uncomfortable,

misunderstood, stigmatized, taboo (workers, 23%; employers, 21%) or just not discussed (workers, 38%; employers, 31%). [Source: Economic Impact of Menopause: Individual and Collective Costs,

fielded September 2023.] WHAT REMAINS TO BE DONE CHANGE IS HAPPENING BUT MORE WORK NEEDS TO BE DONE. * Nearly 6 in 10 (57%) women age 35-plus feel hormonal changes are not discussed enough.

They desire more conversation about both physical (58%) and mental (61%) impacts. [Source:  Perimenopause Is More Than Hot Flashes: What Women Need to Know, fielded September 24–October 4,

2020.] * Over half (54%) of U.S. adult women agree that employers need to do more to support workers in menopause. [Source: Women's Aging Journey, Menopause and Media Representation,

fielded July 31–August 21, 2024.] The same proportion of women 35 and older (54%) feel the same way.  [Source: Economic Impact of Menopause: Individual and Collective Costs, fielded

September 2023.] * Employers acknowledge there is more for them to do, with most (73%) agreeing employers need to do more to support workers in menopause. [Source: Economic Impact of

Menopause: Individual and Collective Costs, fielded September 2023.] * Two in 3 (65%) women believe U.S. policy makers need to do more to ensure all women can access high-quality,

personalized menopause care and treatment, including access to hormone replacement therapy.  [Source: Women's Aging Journey, Menopause and Media Representation, fielded July 31–August

21, 2024.]  This is consistent with the views of female workers 35-plus (64%) who also want policy makers to do more to support women in menopause.  [Source: Economic Impact of Menopause:

Individual and Collective Costs, fielded September 2023.] * Likewise, most employers (74%) would like policy makers to do more to ensure all women can access high-quality, personalized

menopause care and treatment, including access to hormone replacement therapy. [Source: Economic Impact of Menopause: Individual and Collective Costs, fielded September 2023.] RETURN TO AARP

RESEARCH INSIGHTS